In animal models of NAFLD, LA reduced obesity and lipid accumulation in the liver, suppressed the expression of CYP2E1 and H2O2 production, and restored the lowered activity of antioxidant enzymes [37,38,49,50]. The gene discussed is CYP2E1; the disease is obesity disorder.